JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. [electronic resource]
Producer: 19990330Description: 116-25 p. digitalISSN:- 0960-9822
- Animals
- Antibodies, Monoclonal -- immunology
- Apoptosis
- B-Lymphocytes -- immunology
- Dexamethasone -- pharmacology
- Drug Resistance
- Gene Targeting
- Isoenzymes -- deficiency
- Lymphocyte Activation -- drug effects
- Mice
- Mice, Knockout
- Mitogen-Activated Protein Kinase 9
- Mitogen-Activated Protein Kinases
- Muromonab-CD3 -- pharmacology
- Protein Kinases -- deficiency
- RNA Splicing
- T-Lymphocytes -- cytology
- Ultraviolet Rays
- fas Receptor -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.